HF-158K1 by HighField Biopharmaceuticals for Pancreatic Cancer: Likelihood of Approval

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Pancreatic Cancer.

Spell Check-Up: Can You Spell These Medical Words?

Welcome to Spell Check-Up, a game where your medical spelling skills are put to the test. We give you the definition of a healthcare-related word

August 24, 2023

Inflation Reduction Act’s $35 insulin cap linked to rise in prescription fills

The Inflation Reduction Act’s policy capping out-of-pocket costs for insulin to $35 for a month’s supply led to increases in the total number of insulin

July 25, 2023

Globus Medical gets FDA nod for ortho robot

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Globus Medical received 510(k) clearance

June 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.